摘要
本文报道一例氨苯砜治疗麻风致粒细胞缺乏症患者,本例患者HLA-B*1301基因检测结果为阴性,容易让医生忽视氨苯砜导致的药物不良反应,故此病例报道需引起皮肤科医生的警惕。
We report a case of agranulocytosis caused by dapsone in the treatment of leprosy.The result of HLA-B*1301 gene test in this patient was negative,which easily made doctors ignore the adverse drug reactions caused by dapsone.Therefore,the case report should alert dermatologists.
作者
陈嘉惠
CHEN Jiahui(Department of Dermatology,Foshan Shunde Chronic Disease Prevention Center,Foshan 528300,China)
出处
《中国麻风皮肤病杂志》
2023年第9期686-687,共2页
China Journal of Leprosy and Skin Diseases
